Daiichi Sankyo raises FY2026 revenue forecast to JPY 2.34 trillion

• Daiichi Sankyo forecasts FY2026 revenue of JPY 2.34 trillion, up from its earlier projection of JPY 2.28 trillion.
• Operating profit is projected at JPY 320 billion, versus JPY 315 billion previously; core operating profit remains JPY 360 billion.
• Profit attributable to shareholders is forecast at JPY 251 billion, down from JPY 260 billion previously.
• October guidance puts trastuzumab deruxtecan revenue at JPY 1.06 trillion, up from July's JPY 1.03 trillion forecast.
• First-half revenue rose 19.7% to JPY 1.17 trillion, with trastuzumab deruxtecan revenue increasing 51.4% to JPY 500 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daiichi Sankyo Co. Ltd. published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.